CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

SBI Healthcare Opp Fund-Reg(G)

very highequitypharma & health care
343.65 2.81(0.82%) NAV as on 24 Apr 2024
2.29 % 1 M
53.91 % 1 Y
17.73 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.01

As on 31 Mar, 2024
age-icon Age :

24 yrs 9 m

Since 14 07 ,1999
exit_load Exit Load :

0.5%

aum AUM :

2,626.34 Crs

lock_in Lock-in :

0.50% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.4

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

S&P BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2024
Others 1.37 %
Equity 98.63 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.81 %
Cipla Ltd.7.52 %
Max Healthcare Institute Ltd.6.87 %
Mankind Pharma Ltd.5.26 %
Lonza Group Ag4.75 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs60.45
Hospital & Healthcare Services29.26
Chemicals4.16
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)147.24252.90286.90281.32444.33
Net Assets(Rs Crores) (as on 31-Mar-2024) 853.49 1563.95 1778.29 1589.27 2626.34
Scheme Returns(%)(Absolute)-5.7873.5112.48-1.8658.88
B'mark Returns(%)(Absolute)NANANANANA
Category Rank13/7539/7548/7557/7614/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity343.652.81(0.82%)NAV As on 24 Apr, 202414-Jul-1999Inception Date2,626.34AUM In Cr.53.91%1Y17.73%3Y23.10%5Y16.10%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity30.300.10(0.33%)NAV As on 24 Apr, 202413-Jul-2018Inception Date3,772.32AUM In Cr.56.83%1Y17.44%3Y24.10%5Y21.12%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.220.20(0.64%)NAV As on 24 Apr, 202430-Nov-2018Inception Date2,352.32AUM In Cr.49.84%1Y16.22%3Y25.28%5Y24.18%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity24.760.09(0.38%)NAV As on 24 Apr, 202428-Dec-2015Inception Date878.70AUM In Cr.51.01%1Y15.91%3Y21.81%5Y11.50%Since Inception
Nippon India Pharma Fund(G)Very HighEquity422.622.47(0.59%)NAV As on 24 Apr, 202405-Jun-2004Inception Date7,125.28AUM In Cr.50.73%1Y15.63%3Y22.36%5Y20.70%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity30.840.26(0.85%)NAV As on 24 Apr, 202402-Jul-2018Inception Date2,235.15AUM In Cr.48.15%1Y15.16%3Y23.42%5Y21.36%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.